Outcome after Discontinuation of Second Generation Tyrosine Kinase Inhibitors (TKIs) Used As Frontline Therapy for Patients (pts) with Chronic Phase (CP) Chronic Myeloid Leukemia (CML)

被引：0
|
作者：
Abdelall, Waleed
Kantarjian, Hagop M.
Devendra, K. C.
Akosile, Mary
Borthakur, Gautam
Verstovsek, Srdan
Daver, Naval
Pemmaraju, Naveen
Naqvi, Kiran
Garcia-Manero, Guillermo
Thompson, Philip A.
Ferrajoli, Alessandra
Ravandi, Farhad
Konopleva, Marina
DiNardo, Courtney D.
Jabbour, Elias J.
Cortes, Jorge E.
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5248
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Permanent Discontinuation of Tyrosine Kinase Inhibitor Frontline Therapy in Patients with Chronic Phase Chronic Myeloid Leukemia Patients during the First 36 Months of Treatment: A "Campus CML" Study
    Latagliata, Roberto
    Capodanno, Isabella
    Miggiano, Maria Cristina
    Iurlo, Alessandra
    Cavazzini, Francesco
    Crescenzi, Sabrina Leonetti
    Russo, Sabina
    Carmosino, Ida
    Bernardelli, Andrea
    Mulas, Olga
    Elena, Chiara
    Binotto, Gianni
    Crisa, Elena
    Di Veroli, Ambra
    Scortechini, Anna Rita
    Basile, Maria
    Crugnola, Monica
    Murgano, Pamela
    Pizzuti, Michele
    Bucelli, Cristina
    Fava, Carmen
    Dalmazzo, Matteo
    Lunghi, Francesca
    Caocci, Giovanni
    Bonifacio, Massimiliano
    Saglio, Giuseppe
    Specchia, Giorgina
    Breccia, Massimo
    Tiribelli, Mario
    BLOOD, 2022, 140 : 3906 - 3907
  • [32] Outcome After Failure of Second Generation Tyrosine Kinase Inhibitors Treatment As First-line Therapy for Patients With Chronic Myeloid Leukemia
    Eghtedar, Alireza
    Kantarjian, Hagop
    Jabbour, Elias
    O'Brien, Susan
    Burton, Elizabeth
    Garcia-Manero, Guillermo
    Verstovsek, Srdan
    Ravandi, Farhad
    Borthakur, Gautam
    Konopleva, Marina
    Quintas-Cardama, Alfonso
    Cortes, Jorge
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2013, 13 (04): : 477 - 484
  • [33] Withdrawal syndrome after tyrosine kinase inhibitors discontinuation in patients with chronic myeloid leukemia
    Chelysheva, Ekaterina Yu
    Petrova, Anna N.
    Shukhov, Oleg A.
    Bykova, Anastasiia, V
    Nemchenko, Irina S.
    Gurianova, Margarita A.
    Tsyba, Nikolay N.
    Turkina, Anna G.
    TERAPEVTICHESKII ARKHIV, 2022, 94 (07) : 836 - 843
  • [34] Incidence of Secondary Malignancies in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) in the Era of Tyrosine Kinase Inhibitors (TKI)
    Sasaki, Koji
    Kantarjian, Hagop M.
    O'Brien, Susan M.
    Ravandi, Farhad
    Konopleva, Marina
    Borthakur, Gautam
    Garcia-Manero, Guillermo
    Wierda, William G.
    Daver, Naval
    Ferrajoli, Alessandra
    Takahashi, Koichi
    Jain, Preetesh
    Rios, Mary B.
    Pierce, Sherry
    Jabbour, Elias J.
    Cortes, Jorge E.
    BLOOD, 2017, 130
  • [35] Does platelet aggregation differ among chronic myeloid leukemia-chronic phase (CML-CP) patients on tyrosine kinase inhibitors (TKIs)? A tertiary center experience
    Moeen, Sawsan M.
    Afifi, Ola A.
    Thabet, Ahmad F.
    Saleh, Medhat A.
    Morad, Mohamed A.
    EGYPTIAN JOURNAL OF HAEMATOLOGY, 2023, 48 (02): : 185 - 190
  • [36] Discontinuation of tyrosine kinase inhibitor (TKI) therapy in chronic myeloid leukemia in chronic phase (CML-CP) in US clinical practice after guideline updates.
    Atallah, Ehab L.
    Sadek, Islam
    Maegawa, Rodrigo O.
    Cao, Xiting
    Latremouille-Viau, Dominick
    Pivneva, Irina
    Rossi, Carmine
    Guerin, Annie
    Kota, Vamsi
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [37] IMPACT OF TYROSINE KINASE INHIBITORS (TKIS) ON THE FERTILITY OF CHRONIC MYELOID LEUKEMIA PATIENTS (CML) IN A SINGLE CENTER IN ALGERIA
    Yamina, B.
    Souad, T.
    Tayeb, A. Mohand
    HAEMATOLOGICA, 2015, 100 : 690 - 691
  • [38] Cause of Death in Resistant and Advanced Chronic Myeloid Leukemia (CML) Patients Treated with Tyrosine Kinase Inhibitors (TKIs).
    McGarry, Lisa J.
    Burudpakdee, Chakkarin
    Gala, Smeet
    Seetasith, Arpamas
    Nanavaty, Merena
    Huang, Hui
    BLOOD, 2014, 124 (21)
  • [39] Chronic Myeloid Leukemia Therapy: Focus on Second-Generation Tyrosine Kinase Inhibitors
    McFarland, K. Leigh
    Wetzstein, Gene A.
    CANCER CONTROL, 2009, 16 (02) : 132 - 140
  • [40] Outcome of Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Patients Treated with Various Frontline Second-Generation Tyrosine Kinase Inhibitors: A Single-Center Experience
    Lee, Sung-Eun
    Choi, Soo Young
    Kim, Soo-Hyun
    Song, Hye-Young
    Yoo, Hea-Lyun
    Lee, Mi-Young
    Kang, Ki-Hoon
    Hwang, Hee-Jeong
    Jang, Eun-Jung
    Kim, Dong-Wook
    BLOOD, 2015, 126 (23)
12345